Colinz Laboratories

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue1.591.581.843.751.68
Expenses1.491.511.723.511.58
EBITDA0.100.070.120.240.10
EBIT0.050.020.090.180.07
Profit Before Tax0.110.130.140.310.13
Net Profit0.090.070.110.230.10
Financial Ratios
Operating Profit Margin6.29%4.43%5.98%6.67%5.95%
Net Profit Margin5.66%4.43%5.98%6.13%5.95%
Earning Per Share (Diluted)0.190.160.440.900.41
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.8.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI